Sort
21,281 grants matching “influenza”
Microfabricated Device for Rapid, Portable, Viral Genome
$437,482University Of Michigan At Ann Arbor · R21 · FY2004 · AI
Development of a Human Lymph node-on a Chip Microphysiological System for Evaluation of Vaccine Effectiveness against Infectious Diseases
$437,477Weiqiang Chen · New York University · R21 · FY2025 · AI
Diet and the CPT1A arctic variant: Impact on the Health of Alaska Native Children
$437,407David M Koeller · Oregon Health & Science University · R01 · FY2017 · HD
Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies
$437,310Dusan Bogunovic · Columbia University Health Sciences · R01 · FY2025 · AI
Epidemiology of Infectious Diseases
$437,283Yonatan H Grad · Harvard University D/B/A Harvard School Of Public Health · T32 · FY2025 · AI
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.
$437,138Mark M Davis · Stanford University · U19 · FY2021 · AI
Novel synthetic TLR4 agonists
$437,073Juhienah Khalaf · Inimmune Corporation · R44 · FY2019 · AI
Functional and genetic constraints on influenza virus replication and fidelity
$437,039Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
Optimization of novel immunogen design to elicit broadly protective immune responses against influenza viruses
$437,036Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2022 · AI
Correlations: Structure-Dynamics-Function in Channels
$436,796Timothy A Cross · Florida State University · R01 · FY2013 · AI
Immunotherapy for acute lung injury secondary to influenza
$436,772Paul R Knight · State University Of New York At Buffalo · R01 · FY2021 · HL
Immunotherapy for acute lung injury secondary to influenza
$436,772Paul R Knight · State University Of New York At Buffalo · R01 · FY2023 · HL
Immunotherapy for acute lung injury secondary to influenza
$436,772Paul R Knight · State University Of New York At Buffalo · R01 · FY2020 · HL
Immunotherapy for acute lung injury secondary to influenza
$436,772Paul R Knight · State University Of New York At Buffalo · R01 · FY2022 · HL
Enhanced Surveillance-Newly Vaccine Preventable Diseases
$436,768Peter G Szilagyi · University Of Rochester · U01 · FY2009 · IP
Shifting immunodominance of humoral immunity against influenza viruses
$436,669Jenna Guthmiller · University Of Colorado Denver · DP2 · FY2024 · AI
Systems Immunogenetics Core
$436,619Shannon K McWeeney · Univ Of North Carolina Chapel Hill · U19 · FY2013 · AI
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
$436,605Mark W Albers · Massachusetts General Hospital · U01 · FY2022 · DC
TRIM mediated host antiviral responses during influenza virus infections
$436,591Adolfo Garcia-Sastre · University Of Southern California · U19 · FY2011 · AI
Single cell molecular analysis of influenza vaccine responses in elderly individuals
$436,516Spyros A Kalams · Vanderbilt University Medical Center · R01 · FY2023 · AI
Siglec Modulation of Inflammatory Responses
$436,509Ajit P Varki · University Of California, San Diego · P01 · FY2014 · HL
Alphavirus replicon vectors as dose-sparing adjuvants for Influenza vaccines.
$436,414Jonathan Smith · Alphavax Human Vaccines, Inc. · U01 · FY2008 · AI
Fine-tuning the Neutrophilic Response to Pneumonia
$436,335Mark Roberts Looney · University Of California, San Francisco · R01 · FY2019 · AI
Fine-tuning the Neutrophilic Response to Pneumonia
$436,335Mark Roberts Looney · University Of California, San Francisco · R01 · FY2020 · AI
Analysis of Host-Pathogen Interactions
$436,298Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI